Rapport Therapeutics (NasdaqGM:RAPP) FY Conference September 17, 2025 11:20 AM ET Company ParticipantsAbraham Ceesay - CEO & DirectorTroy Ignelzi - CFOConference Call ParticipantsJoseph Thome - MD & Senior Biotechnology Equity Research AnalystJoseph ThomeHi everyone, and thank you for joining us at our 2025 fifth annual Novel Mechanisms in Neuropsychiatry and Epilepsy Summit. I'm Joe Thomore, the Senior Biotech Analyst here on the team at TD Cowen, and it is my pleasure to have with us today the team from R ...